Source: Chemical Engineering

Fujifilm Diosynth: Fujifilm Diosynth Biotechnologies completes expansion at manufacturing site in California

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, announced the completion of an expansion of its cell-therapy manufacturing facility in Thousand Oaks, California. The event also celebrated the recent European Medicines Agency (EMA) site issuance of a Certificate of GMP Compliance of a Manufacturer. This [...] The post Fujifilm Diosynth Biotechnologies completes expansion at manufacturing site in California appeared first on Chemical Engineering.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Lars Petersen's photo - President & CEO of Fujifilm Diosynth

President & CEO

Lars Petersen

CEO Approval Rating

83/100

Read more